ESTIMASI PANAS GAMMA PADA PRODUKSI RADIOISOTOP Lu-177, Ir-192, DAN Au-198 DI TERAS MOLIBDENUM RSG-GAS

ESTIMASI PANAS GAMMA PADA PRODUKSI RADIOISOTOP Lu-177, Ir-192, DAN Au-198 DI TERAS MOLIBDENUM RSG-GAS

ESTIMASI PANAS GAMMA PADA PRODUKSI RADIOISOTOP Lu-177, Ir-192, DAN Au-198 DI TERAS MOLIBDENUM RSG-GAS. Panas gamma (Gamma heating) merupakan isu penting terkait keselamatan fasilitas iradiasi suatu reaktor dan sampel iradiasinya. Panas gamma dihasilkan dari interaksi energi gamma dengan material ta...

Full description

Bibliographic Details
Main Authors:	Dewi Nur Riskiana, Anis Rohanda, R Farzand Abdullatif
Format:	Article
Language:	English
Published:	Pusat Teknologi Bahan Bakar Nuklir 2022-06-01
Series:	Urania
Online Access:	http://jurnal.batan.go.id/index.php/urania/article/view/6654

Similar Items

KARAKTERISASI RADIOACTIVE FISSION WASTE (RFW) DARI PRODUKSI RADIOISOTOP LUTESIUM-177 MENGGUNAKAN PROGRAM ORIGEN2
by: Lena Rosmayani, et al.
Published: (2022-06-01)

Half-life measurement of the medical radioisotope 177Lu produced from the 176Yb(n,γ) reaction
by: Ferreira K.M., et al.
Published: (2017-01-01)

Specific Radioactivity of Neutron Induced Radioisotopes: Assessment Methods and Application for Medically Useful 177Lu Production as a Case
by: Van So Le
Published: (2011-01-01)

Anatomy-based correction of kidney PVE on $$^{177}\text{Lu}$$ 177 Lu SPECT images
by: Julien Salvadori, et al.
Published: (2024-02-01)

Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates
by: Peter Frøhlich Staanum, et al.
Published: (2021-11-01)

Evaluation of the 177mLu-concentration in in-house produced 177Lu-radiopharmaceuticals and commercially available Lutathera®
by: Matthias Balzer, et al.
Published: (2023-11-01)

Metallacages with 2,6-dipicolinoylbis(N,N-dialkylthioureas) as novel platforms in nuclear medicine for 68Ga, 177Lu and 198Au
by: Anna Baitullina, et al.
Published: (2023-11-01)

Improved quality control of [177Lu]Lu-PSMA I&T
by: Martin Kraihammer, et al.
Published: (2023-03-01)

Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry
by: Andreas Rinscheid, et al.
Published: (2020-06-01)

Extravasation of [177Lu]Lu-DOTATOC: case report and discussion
by: Anne Kirstine Arveschoug, et al.
Published: (2020-06-01)

Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies
by: Alexander Wurzer, et al.
Published: (2024-02-01)

Radionuclide generator-based production of therapeutic 177Lu from its long-lived isomer 177mLu
by: Rupali Bhardwaj, et al.
Published: (2019-07-01)

Features and Practical Aspects of Radiochemical Purity Determination of Receptor-Specific Lu-177 Radiopharmaceuticals as Exemplified by [<sup>177</sup>Lu]Lu–PSMA-617
by: A. A. Larenkov, et al.
Published: (2022-12-01)

Inter-comparison of quantitative imaging of lutetium-177 (177Lu) in European hospitals
by: Jill Wevrett, et al.
Published: (2018-08-01)

Acquisition Conditions for Lu-177 DOTATATE Imaging
by: Yuri Sagisaka, et al.
Published: (2024-01-01)

Production of Carrier Added 177Lu in HFETR
by: HU Yingjiang;WANG Lei;WU Jianrong;LI Bo;LUO Ning;CHEN Yunming;ZENG Junjie;SUN Zhizhong;JIA Zhijun;ZHANG Jinsong
Published: (2023-02-01)

The Recent Research Development of 177Lu Radiopharmaceuticals
by: YANG Yuchuan;KAN Wentao;YANG Xia;WEI Hongyuan;ZHUO Liangang;WANG Jing;LIAO Wei;ZHAO Peng;WANG Guanquan
Published: (2022-06-01)

Lutetium Lu-177 Dotatate Flare Reaction
by: Andrew L. Salner, MD, et al.
Published: (2021-01-01)

Development of 177Lu-phytate Complex for Radiosynovectomy
by: Hassan Yousefnia, et al.
Published: (2013-05-01)

Prediction of [177Lu]Lu-DOTA-TATE therapy response using the absorbed dose estimated from [177Lu]Lu-DOTA-TATE SPECT/CT in patients with metastatic neuroendocrine tumour
by: Sejin Ha, et al.
Published: (2024-02-01)

First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [<sup>177</sup>Lu]Lu-DOTA.SA.FAPi and [<sup>177</sup>Lu]Lu-DOTAGA.(SA.FAPi)<sub>2</sub>
by: Sanjana Ballal, et al.
Published: (2021-11-01)

Distinct In Vitro Binding Profile of the Somatostatin Receptor Subtype 2 Antagonist [<sup>177</sup>Lu]Lu-OPS201 Compared to the Agonist [<sup>177</sup>Lu]Lu-DOTA-TATE
by: Rosalba Mansi, et al.
Published: (2021-12-01)

Individualisation of radiation protection recommendations for patients treated with [177Lu]Lu-DOTA-TATE
by: Teresa Monserrat Fuertes, et al.
Published: (2023-09-01)

Developments in 177Lu-based radiopharmaceutical therapy and dosimetry
by: Siju C. George, et al.
Published: (2023-07-01)

Stability in the production and transport of 177Lu labelled PSMA
by: Cristian Antonio Wieczorek Villas Boas, et al.
Published: (2021-03-01)

Preparation of gold-198 radioisotope and evaluation of the effect of grafting of 198Au on functionalized silica nanoparticles on its biodistribution: introducing a new theranostic agent
by: A. Rasekholghol, et al.
Published: (2021-09-01)

Matching-adjusted indirect treatment comparison of [177Lu]Lu-DOTA-TATE, everolimus and sunitinib in advanced, unresectable gastroenteropancreatic neuroendocrine tumours: Relative effectiveness of [177Lu]Lu-DOTA-TATE in gastroenteropancreatic neuroendocrine tumours
by: Mohid S. Khan, et al.
Published: (2021-11-01)

Enhancing [ 177 Lu]Lu-DOTA-TATE therapeutic efficacy in vitro by combining it with metronomic chemotherapeutics
by: Cheng, J, et al.
Published: (2024)

Corrigendum: Developments in 177Lu-based radiopharmaceutical therapy and dosimetry
by: Siju C. George, et al.
Published: (2024-04-01)

Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
by: Madhav Prasad Yadav, et al.
Published: (2019-02-01)

Production route analysis of a therapeutic radionuclide 177Lu
by: A. K. M. Rezaur Rahman, et al.
Published: (2022-09-01)

177Lu-DOTATATE therapy in metastatic/ inoperable pheochromocytoma-paraganglioma
by: Sanjeet Kumar Jaiswal, et al.
Published: (2020-09-01)

Quantitative accuracy of 177Lu SPECT imaging for molecular radiotherapy.
by: Emilio Mezzenga, et al.
Published: (2017-01-01)

An exceptional response to 177LuPSMA undermined by neuroendocrine transformation
by: Pretoria Bilinski, et al.
Published: (2021-01-01)

Efficacy of 177Lu-Dotatate Therapy in the Treatment of Recurrent Meningioma
by: Anza Zahid, MBBS, et al.
Published: (2021-02-01)

Preparation and Preliminary Biological Evaluation of 177Lu Labelled Rituximab
by: MA Xiu-feng1;ZHANG Jun-li2;LI Hong-yu1,2;LIANG Ji-xin1;YANG Yun2;YANG Chun-hui2;DU Jin1,3
Published: (2014-02-01)

Direct measurement of the inelastic neutron acceleration by 177mLu
by: Menelle A., et al.
Published: (2010-03-01)

Isotope separation of 176Lu a precursor to 177Lu medical isotope using broadband lasers
by: M. V. Suryanarayana
Published: (2021-03-01)

Comparison of different methods for post-therapeutic dosimetry in [177Lu]Lu-PSMA-617 radioligand therapy
by: Florian Rosar, et al.
Published: (2021-05-01)

Estimation of relative biological effectiveness of 225Ac compared to 177Lu during [225Ac]Ac-PSMA and [177Lu]Lu-PSMA radiopharmaceutical therapy using TOPAS/TOPAS-nBio/MEDRAS
by: Mikhail Rumiantcev, et al.
Published: (2023-09-01)